NCT02486939View on ClinicalTrials.gov

A Long Term Safety Extension Study (CHS-0214-05)

PHASE3CompletedINTERVENTIONAL
Enrollment

359

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

September 30, 2017

Study Completion Date

October 31, 2017

Conditions
Rheumatoid ArthritisPlaque Psoriasis
Interventions
DRUG

CHS-0214

Open label

Trial Locations (1)

870-0823

Oribe Clinic of Rheumatism and Medicine, Ōita

Sponsors
All Listed Sponsors
collaborator

Daiichi Sankyo Co., Ltd.

INDUSTRY

collaborator

Shire

INDUSTRY

lead

Coherus Oncology, Inc.

INDUSTRY